Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023
October 30 2023 - 6:00PM
Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced
that its third quarter 2023 financial results will be released
after market close on Monday, November 6, 2023. Starting
at 5:00 p.m. ET on November 6, 2023, Coherus’
management team will host a conference call and webcast to discuss
financial results and provide a general business update.
Conference Call Information
When: Monday, November 6, 2023, starting
at 5:00 p.m. Eastern TimeTo access the conference call, please
pre-register through the following link to receive dial-in
information and a personal PIN to access the live
call: https://register.vevent.com/register/BI0eececfba52f4f83a7438c9f002fabc4
Webcast:
https://edge.media-server.com/mmc/p/z2fatkzx
A press release containing the third quarter
financial results and related materials will be available at
https://investors.coherus.com prior to the start of the conference
call. Please also review our Quarterly Report on Form 10-Q for the
quarter ended September 30, 2023, which will be available at
https://investors.coherus.com and available via EDGAR on the SEC’s
website at www.sec.gov on November 6, 2023 for more
information about our third quarter financial results.
A live and archived webcast will be available on
the “Investors” section of the Coherus website
at http://investors.coherus.com.
Coherus Contact Information:Jodi
SieversVP, Corporate CommunicationsIR@coherus.com
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From May 2024 to Jun 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jun 2023 to Jun 2024